Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis
Cristina Delgado-Arévalo, … , Isidoro González Álvaro, Enrique Martin-Gayo
Cristina Delgado-Arévalo, … , Isidoro González Álvaro, Enrique Martin-Gayo
Published October 4, 2022
Citation Information: JCI Insight. 2022;7(22):e152886. https://doi.org/10.1172/jci.insight.152886.
View: Text | PDF
Research Article Cell biology

NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis

  • Text
  • PDF
Abstract

The individual contribution of specific myeloid subsets such as CD1c+ conventional DC (cDC) to perpetuation of rheumatoid arthritis (RA) pathology remains unclear. In addition, the specific innate sensors driving pathogenic activation of CD1c+ cDC in patients with RA and their functional implications have not been characterized. Here, we assessed phenotypical, transcriptional, and functional characteristics of CD1c+ and CD141+ cDC and monocytes from the blood and synovial fluid of patients with RA. Increased levels of CCR2 and the IgG receptor CD64 on circulating CD1c+ cDC was associated with the presence of this DC subset in the synovial membrane in patients with RA. Moreover, synovial CD1c+ cDC are characterized by increased expression of proinflammatory cytokines and high abilities to induce pathogenic IFN-γ+IL-17+CD4+ T cells in vitro. Finally, we identified the crosstalk between Fcγ receptors and NLRC4 as a potential molecular mechanism mediating pathogenic activation, CD64 upregulation, and functional specialization of CD1c+ cDC in response to dsDNA-IgG in patients with RA.

Authors

Cristina Delgado-Arévalo, Marta Calvet-Mirabent, Ana Triguero-Martínez, Enrique Vázquez de Luis, Alberto Benguría-Filippini, Raquel Largo, Diego Calzada-Fraile, Olga Popova, Ildefonso Sánchez-Cerrillo, Ilya Tsukalov, Roberto Moreno-Vellisca, Hortensia de la Fuente, Gabriel Herrero-Beaumont, Almudena Ramiro, Francisco Sánchez-Madrid, Santos Castañeda, Ana Dopazo, Isidoro González Álvaro, Enrique Martin-Gayo

×

Figure 2

RNA-Seq analysis of differential transcriptional signatures in circulating and synovial Mo, CD1c+, and CD141+ cDC from patients with RA.

Options: View larger image (or click on image) Download as PowerPoint
RNA-Seq analysis of differential transcriptional signatures in circulati...
(A) Number of individual (left) and overlapping (center, Venn diagram) significant differentially expressed genes (DEG P < 0.05 after FDR correction considering a log2 fold change [log2FC] > 1.5 and < –1.5) between circulating Mo, CD1c+, and CD141+ cDC from n = 4 untreated patients with RA compared with n = 4 healthy controls (HC). (B) Significance of selected upregulated (positive Z score; red), downregulated (negative Z score; blue), or undetermined (0 or not predicted Z score; gray) canonical pathways predicted by IPA (full analysis shown in Supplemental Table 5) for DEG from Mo, CD1c+ cDC, and CD141+ cDC from RA versus HC. *P < 0.05; **P < 0.021; ***P < 0.001; ****P < 0.0001. (C) Circos plot analyzing level of connection and shared genes between some of the pathways significantly altered in CD1c+ cDC from the blood of patients with RA shown in B. Genes within each pathway are ordered according to upregulated (red scale) and downregulated (blue scale) transcriptional levels. Quantification of interactions between pathways in the circos plot is illustrated on the heatmap shown on the right. (D) Venn diagram of overlapping significant DEG in CD1c+ cDC from the peripheral blood (PB) and synovial fluid (SF) from RA individuals compared with healthy controls (HC) or calcium pyrophosphate deposition (CPPD) crystal–associated arthropathy patients. (E) Significance of selected pathways for 73 overlapping DEG and 905 nonoverlapping DEG in CD1c+ cDC from SF mentioned in D, predicted by DAVID.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts